- call +1-201-465-4211
- email sales@mrinsights.biz
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
Scope of the Report:
In terms of applications, diagnostics accounted for major share of the global cancer biomarkers market in 2017.
The worldwide market for Cancer Biomarker is expected to grow at a CAGR of roughly 12.2% over the next five years, will reach 23100 million US$ in 2023, from 11600 million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Cancer Biomarker in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen N.V.
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Protein Biomarker
Genetic Biomarker
Market Segment by Applications, can be divided into
Diagnostics
Research
Prognostics
Risk Assessment
Other Applications
There are 15 Chapters to deeply display the global Cancer Biomarker market.
Chapter 1, to describe Cancer Biomarker Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Biomarker, with sales, revenue, and price of Cancer Biomarker, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Biomarker, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Biomarker market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Biomarker sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cancer Biomarker Introduction
1.2 Market Analysis by Type
1.2.1 Protein Biomarker
1.2.2 Genetic Biomarker
1.3 Market Analysis by Applications
1.3.1 Diagnostics
1.3.2 Research
1.3.3 Prognostics
1.3.4 Risk Assessment
1.3.5 Other Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Business Overview
2.1.2 Cancer Biomarker Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bio-Rad Laboratories
2.2.1 Business Overview
2.2.2 Cancer Biomarker Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bio-Rad Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche Diagnostics
2.3.1 Business Overview
2.3.2 Cancer Biomarker Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qiagen N.V.
2.4.1 Business Overview
2.4.2 Cancer Biomarker Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Qiagen N.V. Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Illumina
2.5.1 Business Overview
2.5.2 Cancer Biomarker Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Illumina Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GE Healthcare
2.6.1 Business Overview
2.6.2 Cancer Biomarker Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GE Healthcare Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Agilent Technologies
2.7.1 Business Overview
2.7.2 Cancer Biomarker Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Agilent Technologies Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biomérieux SA
2.8.1 Business Overview
2.8.2 Cancer Biomarker Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biomérieux SA Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck & Co.
2.9.1 Business Overview
2.9.2 Cancer Biomarker Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck & Co. Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Abbott Laboratories
2.10.1 Business Overview
2.10.2 Cancer Biomarker Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Abbott Laboratories Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Becton, Dickinson and Company
2.11.1 Business Overview
2.11.2 Cancer Biomarker Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Becton, Dickinson and Company Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Danaher Corporation
2.12.1 Business Overview
2.12.2 Cancer Biomarker Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Danaher Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Myriad Genetics
2.13.1 Business Overview
2.13.2 Cancer Biomarker Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Myriad Genetics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Sysmex Corporation
2.14.1 Business Overview
2.14.2 Cancer Biomarker Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Sysmex Corporation Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Hologic
2.15.1 Business Overview
2.15.2 Cancer Biomarker Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Hologic Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Quest Diagnostics
2.16.1 Business Overview
2.16.2 Cancer Biomarker Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Quest Diagnostics Cancer Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Biomarker Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Biomarker Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Biomarker Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Biomarker Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Biomarker Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Biomarker Market Analysis by Regions
4.1 Global Cancer Biomarker Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Biomarker Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Biomarker Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Biomarker Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Biomarker Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Biomarker Sales and Growth Rate (2013-2018)
4.5 South America Cancer Biomarker Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Biomarker Sales and Growth Rate (2013-2018)
5 North America Cancer Biomarker by Countries
5.1 North America Cancer Biomarker Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Biomarker Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Biomarker Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Biomarker Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Biomarker Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Biomarker Sales and Growth Rate (2013-2018)
6 Europe Cancer Biomarker by Countries
6.1 Europe Cancer Biomarker Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Biomarker Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Biomarker Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Biomarker Sales and Growth Rate (2013-2018)
6.3 UK Cancer Biomarker Sales and Growth Rate (2013-2018)
6.4 France Cancer Biomarker Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Biomarker Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Biomarker Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Biomarker by Countries
7.1 Asia-Pacific Cancer Biomarker Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Biomarker Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Biomarker Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Biomarker Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Biomarker Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Biomarker Sales and Growth Rate (2013-2018)
7.5 India Cancer Biomarker Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Biomarker Sales and Growth Rate (2013-2018)
8 South America Cancer Biomarker by Countries
8.1 South America Cancer Biomarker Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Biomarker Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Biomarker Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Biomarker Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Biomarker Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Biomarker Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Biomarker by Countries
9.1 Middle East and Africa Cancer Biomarker Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Biomarker Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Biomarker Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Biomarker Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Biomarker Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Biomarker Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Biomarker Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Biomarker Sales and Growth Rate (2013-2018)
10 Global Cancer Biomarker Market Segment by Type
10.1 Global Cancer Biomarker Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Biomarker Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Biomarker Revenue and Market Share by Type (2013-2018)
10.2 Protein Biomarker Sales Growth and Price
10.2.1 Global Protein Biomarker Sales Growth (2013-2018)
10.2.2 Global Protein Biomarker Price (2013-2018)
10.3 Genetic Biomarker Sales Growth and Price
10.3.1 Global Genetic Biomarker Sales Growth (2013-2018)
10.3.2 Global Genetic Biomarker Price (2013-2018)
11 Global Cancer Biomarker Market Segment by Application
11.1 Global Cancer Biomarker Sales Market Share by Application (2013-2018)
11.2 Diagnostics Sales Growth (2013-2018)
11.3 Research Sales Growth (2013-2018)
11.4 Prognostics Sales Growth (2013-2018)
11.5 Risk Assessment Sales Growth (2013-2018)
11.6 Other Applications Sales Growth (2013-2018)
12 Cancer Biomarker Market Forecast (2018-2023)
12.1 Global Cancer Biomarker Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Biomarker Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Biomarker Market Forecast (2018-2023)
12.2.2 Europe Cancer Biomarker Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Biomarker Market Forecast (2018-2023)
12.2.4 South America Cancer Biomarker Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Biomarker Market Forecast (2018-2023)
12.3 Cancer Biomarker Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Biomarker Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Biomarker Market Share Forecast by Type (2018-2023)
12.4 Cancer Biomarker Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Biomarker Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Biomarker Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Biomarker Picture
Table Product Specifications of Cancer Biomarker
Figure Global Sales Market Share of Cancer Biomarker by Types in 2017
Table Ca
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
